Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Villin like suppresses nasopharyngeal carcinoma proliferation by downregulating MYC.

View through CrossRef
Abstract The initial manifestations of nasopharyngeal carcinoma (NPC) are subtle and imperceptible, leading to unfavorable clinical outcomes and limited therapeutic alternatives among Southeast Asian populations. Deletion of chromosome 3p is a commonly observed genetic alteration in NPC. In our endeavor to elucidate the key genes and pathways driving NPC growth, we have discovered that Villin like (VILL), located at 3p22.2, functions as a novel tumor suppressor gene (TSG) with significantly diminished expression levels in NPC. This finding underscores the tremendous potential of VILL as an unexplored molecule warranting further investigation. Overexpressing VILL effectively inhibits proliferation by inducing G1 phase arrest in NPC cells while its knockdown yields contrasting effects on cell growth regulation. Furthermore, our study demonstrates that VILL targets MYC. Knockdown of VILL and overexpression of MYC significantly enhance proliferation in an immortal nasopharyngeal epithelial cell line NP69. Moreover, we are the first to report that VILL plays a tumor suppressive role in NPC. Consequently, VILL emerges as a novel prognostic biomarker and a potential therapeutic candidate for NPC.
Springer Science and Business Media LLC
Title: Villin like suppresses nasopharyngeal carcinoma proliferation by downregulating MYC.
Description:
Abstract The initial manifestations of nasopharyngeal carcinoma (NPC) are subtle and imperceptible, leading to unfavorable clinical outcomes and limited therapeutic alternatives among Southeast Asian populations.
Deletion of chromosome 3p is a commonly observed genetic alteration in NPC.
In our endeavor to elucidate the key genes and pathways driving NPC growth, we have discovered that Villin like (VILL), located at 3p22.
2, functions as a novel tumor suppressor gene (TSG) with significantly diminished expression levels in NPC.
This finding underscores the tremendous potential of VILL as an unexplored molecule warranting further investigation.
Overexpressing VILL effectively inhibits proliferation by inducing G1 phase arrest in NPC cells while its knockdown yields contrasting effects on cell growth regulation.
Furthermore, our study demonstrates that VILL targets MYC.
Knockdown of VILL and overexpression of MYC significantly enhance proliferation in an immortal nasopharyngeal epithelial cell line NP69.
Moreover, we are the first to report that VILL plays a tumor suppressive role in NPC.
Consequently, VILL emerges as a novel prognostic biomarker and a potential therapeutic candidate for NPC.

Related Results

<i>MYC</i> rearrangement but not extra <i>MYC</i> copies is an independent prognostic factor in patients with mantle cell lymphoma
<i>MYC</i> rearrangement but not extra <i>MYC</i> copies is an independent prognostic factor in patients with mantle cell lymphoma
Mantle cell lymphoma (MCL) with MYC rearrangement (MYC-R) is rare and little is known about the importance of MYC extra copies (EC) in the absence of MYC-R in MCL patients. This st...
Improving immunotherapy in high-grade B-cell lymphoma
Improving immunotherapy in high-grade B-cell lymphoma
MYC is a transcription factor that upon deregulation acts as an oncogene. Cancer patients with MYC overexpression face significant worse outcomes to treatment with (immuno)chemothe...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 5833: Targeting the transcription co-activator TAZ inhibits MYC-driven medulloblastoma
Abstract 5833: Targeting the transcription co-activator TAZ inhibits MYC-driven medulloblastoma
Abstract Medulloblastoma (MB), the most common malignant pediatric brain tumor, results in significant neurological, intellectual and physical disability or death. F...
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract 1872: Targeting MYC-driven medulloblastoma using inhibitors of glutamine metabolism.
Abstract Medulloblastoma is the most common malignant brain tumor in children. Currently, treatment consists of surgical resection, chemotherapy, and whole brain and...
In vivo analysis of functional domains from villin and gelsolin.
In vivo analysis of functional domains from villin and gelsolin.
Transfected CV1 cells were used to compare the in vivo effects of various domains of villin and gelsolin. These two homologous actin modulating proteins both contain a duplicated s...

Back to Top